Preimplantation Genetic Screening
Improve the chances of reproductive success by
selecting chromosomally normal embryos.
OVERVIEW
Increase Healthy Pregnancies
PGS is a genetic test performed on embryos to identify numerical chromosomal abnormalities (aneuploidy). This test is performed on embryos before transfer to the uterus by analyzing all embryos generated in an IVF treatment cycle. Those free of chromosomal aneuploidy can be selectively transferred. As a result, the pregnancy rates per transfer are significantly increased, and the miscarriage rates decreased.
Who is it for?
Pre-implantation genetic screens (PGS) enable the selection of embryos with a normal number of chromosomes, increasing the efficiency of IVF for all couples, including those with:
- Two or more unsuccessful IVF cycles
- Multiple miscarriages in the past
- Previous pregnancies with chromosomal abnormalities
- Balanced structural chromosomal rearrangements in parental DNA
Why Preimplantation Genetic Screening
Greater implantation rates and improved IVF clinical outcomes.
Mitigates several reproductive challenges
Allows for single embryo transfers
PGS Brochure for Physician
Lab Genomics Laboratory Services meets your needs by using state of the art automated genetic testing to provide preventative, predictive & personalized medicine.
PGS Brochure for Patient
Revolutionizing healthcare with novel single-cell genetics, Pre-implantation Genetic Screens (PGS) detect chromosomal abnormalities in embryonic DNA.